|Articles|June 1, 1996

June 1996
Volume 2
Issue 6

Infertility Treatment and the IVF Patient in Managed Care Settings

Author(s)David Frankfurter, MD, Alan H. DeCherney, MD

Download PDF: Infertility Treatment and the IVF Patient in Managed Care Settings

Articles in this issue

about 30 years ago

Article

Consequences of Prior Authorization Programs -- A Case Example: DDAVP in Pediatric Nocturnal Enuresis

about 30 years ago

Article

Chest Pain

about 30 years ago

Article

The Corporatization of American Medicine: The Impact of Managed Care on the Doctor-Patient Relationship

about 30 years ago

Article

Correspondence regarding, "Diagnosis and Eradication of Helicobacter pylori in the Management of Peptic Ulcer Disease: A Decision Analysis Model"

about 30 years ago

Article

Correspondence regarding Computed Tomography Scans

about 30 years ago

Article

Outcome and Cost Analysis of Preterm Premature Rupture of Membranes in an Outpatient Setting

about 30 years ago

Article

An Alternative Framework for Evaluating the Efficiency of Managed Care

about 30 years ago

Article

Management of Dyspepsia: A Decision Analysis Model

about 30 years ago

Article

The Effectiveness of an Influenza Vaccination Program in an HMO Setting

about 30 years ago

Article

The Emerging Use of Economic Models in the Life-Cycle of Pharmaceutical Products

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Infertility Treatment and the IVF Patient in Managed Care Settings

Articles in this issue

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis